CD2-Hk2tm1Laak/Kctt

Status

Available to order

EMMA IDEM:02073
Citation informationRRID:IMSR_EM:02073 

Research Resource Identifiers (RRID) are persistent unique ID numbers assigned to help researchers cite key resources (e.g. antibodies, model organisms and software projects) in the biomedical literature to improve transparency and reproducibility in research. See https://www.rrids.org/ for more information.

International strain nameCD2-Hk2tm1Laak/Kctt
Alternative nameUkko1; Hk2+/-
Strain typeTargeted Mutant Strains : Knock-out
Allele/Transgene symbolHk2tm1Laak
Gene/Transgene symbolHk2

Information from provider

ProviderSami Heikkinen
Provider affiliationIGBMC
Genetic informationA neomycin resistance cassette was inserted into exon 4 of mouse hexokinase 2 (Hk2) gene.
Phenotypic informationHomozygotes die approximately at embryonic day 7. Heterozygotes are viable but have about 50% reduction in Hk2 enzyme activity in heart, skeletal muscle and white adipose tissue.
References
  • Hexokinase II-deficient mice. Prenatal death of homozygotes without disturbances in glucose tolerance in heterozygotes.;Heikkinen S, Pietilä M, Halmekytö M, Suppola S, Pirinen E, Deeb S S, Jänne J, Laakso M, ;1999;The Journal of biological chemistry;274;22517-23; 10428828
  • Hexokinase II partial knockout impairs exercise-stimulated glucose uptake in oxidative muscles of mice.;Fueger Patrick T, Heikkinen Sami, Bracy Deanna P, Malabanan Carlo M, Pencek R Richard, Laakso Markku, Wasserman David H, ;2003;American journal of physiology. Endocrinology and metabolism;285;E958-63; 12865258
  • Hexokinase II protein content is a determinant of exercise endurance capacity in the mouse.;Fueger Patrick T, Shearer Jane, Krueger Tess M, Posey Kelly A, Bracy Deanna P, Heikkinen Sami, Laakso Markku, Rottman Jeffrey N, Wasserman David H, ;2005;The Journal of physiology;566;533-41; 15878951

Information from EMMA

Archiving centreKarolinska Institutet, Stockholm, Sweden

Disease and phenotype information

Orphanet associated rare diseases, based on orthologous gene matching

MGI phenotypes (allele matching)
  • decreased body weight / MGI
  • embryonic growth retardation / MGI
  • embryonic lethality between somite formation and embryo turning, complete penetrance / MGI
MGI phenotypes (gene matching)
  • decreased body weight / MGI
  • no abnormal phenotype detected / MGI
  • embryonic growth retardation / MGI
  • embryonic lethality between somite formation and embryo turning, complete penetrance / MGI

Literature references

  • Hexokinase II-deficient mice. Prenatal death of homozygotes without disturbances in glucose tolerance in heterozygotes.;Heikkinen S, Pietilä M, Halmekytö M, Suppola S, Pirinen E, Deeb S S, Jänne J, Laakso M, ;1999;The Journal of biological chemistry;274;22517-23; 10428828
  • Hexokinase II partial knockout impairs exercise-stimulated glucose uptake in oxidative muscles of mice.;Fueger Patrick T, Heikkinen Sami, Bracy Deanna P, Malabanan Carlo M, Pencek R Richard, Laakso Markku, Wasserman David H, ;2003;American journal of physiology. Endocrinology and metabolism;285;E958-63; 12865258
  • Hexokinase II protein content is a determinant of exercise endurance capacity in the mouse.;Fueger Patrick T, Shearer Jane, Krueger Tess M, Posey Kelly A, Bracy Deanna P, Heikkinen Sami, Laakso Markku, Rottman Jeffrey N, Wasserman David H, ;2005;The Journal of physiology;566;533-41; 15878951

Information on how we integrate external resources can be found here

Order

Availabilities

Requesting frozen sperm or embryos is generally advisable wherever possible, in order to minimise the shipment of live mice.

  • Frozen embryos. Delivered in 4 weeks (after paperwork in place). €1740*
  • Rederivation of mice from frozen stock, delivery time available upon request . €3880*

Due to the dynamic nature of our processes strain availability may change at short notice. The local repository manager will advise you in these circumstances.

* In addition users have to cover all the shipping costs (including the cost for returning dry-shippers, where applicable).

More details on pricing and delivery times

Practical information

Genotyping protocol

Example health report
(Current health report will be provided later)

Material Transfer Agreement (MTA)
For this strain no provider MTA is needed. Distribution is based on the EMMA conditions only.

EMMA conditions
Legally binding conditions for the transfer

Right strain for your research?

The information provided on this page is, to the best of EMMA’s knowledge, based on data supplied by the original provider. End users are responsible for reviewing these details and for validating the strain and its suitability for their experimental use.​
Not found what you were looking for? Search here for other strains available from EMMA.


Search
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).